We are live on ! Find out more
FP

Flagship Pioneering Portfolio holdings

AUM $1.54B
1-Year Est. Return 86.39%
This Fund
S&P 500
This Quarter Est. Return
+33.84%
1 Year Est. Return
+86.39%
3 Year Est. Return
-13.28%
5 Year Est. Return
-50.7%
10 Year Est. Return
+414.55%
AUM
$299M
AUM Growth
+$15.4M
Cap. Flow
-$62.5M
Cap. Flow %
-20.91%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EDIT icon
Editas Medicine
EDIT
+$32.4M
2
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$30.1M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCRB icon
1
Seres Therapeutics
MCRB
$46.2M
$203M 68.04%
634,144
– –
SYRS
2
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$47.2M 15.78%
320,444
-160,222
-33% -$30.1M
EDIT icon
3
Editas Medicine
EDIT
$404M
$40.2M 13.45%
1,674,435
-1,701,749
-50% -$32.4M
TTOO
4
DELISTED
T2 Biosystems, Inc
TTOO
$8.19M 2.74%
390
– –

Similar funds

SPC
Stony Point Capital New York $1.54B AUM 54.05% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return
SMC
Smith, Moore & Co Clayton, Missouri $1.54B AUM 24.82% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
BOF
Bank of Finland Helsinki, Finland $1.54B AUM 15.84% 1-Year Est. Return
KCM
Kanawha Capital Management Richmond, Virginia $1.54B AUM 21.3% 1-Year Est. Return
CP
Cumberland Partners Toronto, Ontario, Canada $1.54B AUM 27.61% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return

Flagship Pioneering's Q3 2017 Portfolio in Review

As of Q3 2017, Flagship Pioneering held 4 positions worth $299M, up 5.4% from $284M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Flagship Pioneering withdrew a net $62.5M in Q3 2017, reducing 2 holdings. Its largest reduction was Editas Medicine, cutting an estimated $32.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Flagship Pioneering's biggest Q3 2017 reduction was Editas Medicine, cutting an estimated $32.4M.
  • Flagship Pioneering's ten largest holdings make up 100% of its $299M portfolio in Q3 2017.
  • Flagship Pioneering opened 0 new positions and closed 0 in Q3 2017.
  • Flagship Pioneering's portfolio value rose 5.4% quarter-over-quarter to $299M.

Based on Flagship Pioneering's 13F filing for Q3 2017, filed 3 Nov 2017.